Drug Type Chemical drugs |
Synonyms A 7387, A7387 |
Target |
Action inhibitors |
Mechanism NTCP inhibitors(Sodium/bile acid cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cholestasis | Preclinical | United States | 28 Oct 2023 | |
| Hepatitis B | Preclinical | United States | 28 Oct 2023 | |
| Hepatitis D | Preclinical | United States | 28 Oct 2023 |





